At the forefront of pharmaceutical innovation, Virupaksha stands as a beacon of excellence in manufacturing high-purity Fluconazole, crucial for treating severe infections like cryptococcal meningitis. With an unwavering commitment to quality and safety, the company operates under stringent WHO-GMP guidelines, ensuring that every batch produced meets international standards for efficacy and purity.
Their state-of-the-art facilities are not only ISO 9001 certified—confirming their dedication to consistent quality management—but also ISO 14001 certified, highlighting their proactive approach to environmental sustainability in production processes. This meticulous attention to detail underscores Virupaksha’s mission: delivering pharmaceuticals that healthcare professionals can trust while contributing positively to the global community’s health outcomes.
Other Latest News
- ATxEnterprise 2026 Signals Southeast Asia's Shift from AI Experimentation to Enterprise Deployment June 2, 2026 6:07 am Antara Singapore (ANTARA/PRNewswire)- Southeast Asia's transition from AI ambition to real-world enterprise adoption took centre stage this week at Asia Tech x Enterprise (ATxE) 2026, part of Asia Tech x Singapore (ATxSG) that is jointly organised by the …
- Chemical Injection Pump Market to Grow at 7.1% CAGR Through 2033, Persistence Market Research Report June 2, 2026 4:33 am EIN Presswire The chemical injection pump market is driven by oil & gas growth, environmental regulations, and rising use in water treatment, pharma, food, and agriculture. LONDON, LONDON, UNITED KINGDOM, June 1, 2026 /EINPresswire.com/ -- The global …
- Cosmoprof CBE ASEAN back in Bangkok for 5th edition, 24-26 June 2026 June 1, 2026 6:02 pm Premium Beauty News “Now in its 5th edition, Cosmoprof CBE ASEAN continues to grow as a privileged business platform for international brands, manufacturers, distributors, retailers, and beauty professionals interested in developing new opportunities across Thailand, ASEAN …
- Global Medical Courier Market Trends, Growth Analysis, Share & Forecast 2032 June 1, 2026 12:02 pm EIN Presswire WILMINGTON, NEW CASTLE, DE, UNITED STATES, June 1, 2026 /EINPresswire.com/ -- According to a new report published by Allied Market Research, titled, "Medical Courier Market Size, Share, Competitive Landscape and Trend Analysis Report, by …
- N-octyl Pyrrolidone Market to Experience Surge to US$ 408.0 Mn by 2033, Expanding at a CAGR of 5.7% from 2026 to 2033 June 1, 2026 10:25 am EIN Presswire North America leads with ~45% market share, supported by strong pharma infrastructure, strict regulations, and established specialty chemical networks. LONDON, LONDON, UNITED KINGDOM, June 1, 2026 /EINPresswire.com/ -- According to the latest …
- India-US trade talks begin in Delhi; tariffs, AI, pharma cooperation on agenda June 1, 2026 8:41 am ETManufacturing.in The talks come amid growing expectations that the two countries are nearing the conclusion of a broader bilateral trade pact.India and the United States (US) will begin a fresh round of trade negotiations in New Delhi from June 1 to June 4, with both sides …
- Supriya Lifesciences posts ₹276 cr in Q4 FY26, net profit rises 48% May 30, 2026 4:14 am ETPharma.com New Delhi: Pharma inputs manufacturer, Supriya Lifesciences reported a 50.2 per cent year-on-year (YoY) revenue from operations at Rs 276 crore for the quarter ended March this year. Ebitda for the period stood at Rs 97 crore while net profit jumped 48 per …
- Three companies receive Sebi's nod to float IPOs May 29, 2026 10:03 pm ETLegalWorld.com New Delhi, Rodec Pharma, Renny Strips, and Krishna Buildspace have secured Sebi's approval to raise funds through initial public offerings (IPOs), an update with the markets regulator showed on Friday. Renny Strips Ltd, a steel structural products …
- Navigating Pharma Supply with Regional Resilience at CPHI Americas May 29, 2026 7:42 pm Contract Pharma The global pharmaceutical supply chain is going through a structural transformation. The blueprint for pharmaceutical development and manufacturing, built around global optimization, is being systematically dismantled. Facing global disruptions and trade …
- Nigeria Risks Health Insecurity Without Urgent Pharma Reforms, Experts Warn May 29, 2026 9:11 am Leadership Pharmaceutical experts have warned that Nigeria’s rising dependence on imported medicines poses a growing threat to national health security, calling for urgent executive reforms and stronger policy implementation to prevent a deepening crisis. At the 29th …
- Stocks to Watch Today: Physicswallah, Ashok Leyland, GMR Airports and more in focus May 29, 2026 4:25 am News9 Live Escorts Kubota announced the introduction of Kubota Neostar, a significant upgrade to its compact tractor range in the 21–30 HP segment. (Picture Credit: Getty Images) Kolkata: The focus of investors can be on several stocks today. These can be due to …
- Top stocks in news: LIC, PB Fintech, RIL, Wipro, Coal India, Swiggy, GMR Airports, RITES, Lupin May 29, 2026 2:58 am Business Today Indian equity benchmark indices ended marginally down on Wednesday despite easing geopolitical tensions as persistent FII outflows and weak rupee pressurized the equity. The BSE Sensex shed 141.90 points, or 0.19 per cent, to close at 75,867.80, while NSE…
- Global Drug Discovery Market Projected to Surpass USD 174.92 Billion by 2035 – SNS Insider May 28, 2026 10:27 pm Business Upturn U.S. Drug Discovery Market to Hit USD 62.14 Billion by 2035 While Europe Advances Through Precision Medicine and Biologics Innovation. Austin, United States, May 28, 2026 (GLOBE NEWSWIRE) — “The Drug Discovery Market was valued at USD 71.95 billion in 2025 …
- Lactose Market US$3.1 Bn to US$4.6 Bn by 2033 Driven by Dairy Demand Growth May 28, 2026 10:00 pm EIN Presswire The global lactose market is set to grow from US$3.1 Bn in 2026 to US$4.6 Bn by 2033, driven by pharma demand and rising infant formula production LONDON, LONDON, UNITED KINGDOM, May 28, 2026 /EINPresswire.com/ -- The global lactose market is …
- The Role of Innovative Packaging Solutions in Modern Pharma Manufacturing May 28, 2026 3:02 pm Pharma Tech Outlook By Pharma Tech Outlook | Wednesday, May 27, 2026 Fremont, CA: The pharmaceutical industry in the Asia-Pacific (APAC) region is experiencing rapid growth, driven by increasing populations, rising healthcare expenditures, and a growing demand for quality …
- Agilent Technologies, Inc. (NYSE:A) Q2 2026 Earnings Call Transcript May 28, 2026 12:55 pm Insider Monkey Agilent Technologies, Inc. (NYSE:A) Q2 2026 Earnings Call Transcript May 27, 2026 Agilent Technologies, Inc. beats earnings expectations. Reported EPS is $1.49, expectations were $1.41. Operator: Ladies and gentlemen, thank you for joining us, and welcome …
- Validation to velocity: Japan’s pharma model comes under execution pressure May 28, 2026 12:18 pm Pharmaceutical Technology Japan’s pharmaceutical industry – the world’s third largest by market value after the United States and China – has long been associated with methodical development cycles and rigorous technical validation. But the sector is undergoing a gradual yet …
- Robotic Process Automation Market to Reach US$ 25.4 Billion by 2033 Growing at 23.5% CAGR May 28, 2026 7:33 am EIN Presswire Global robotic process automation market to reach US$25.4 Bn by 2033 from US$5.8 Bn in 2026, growing at a CAGR of 23.5% driven by enterprise automation demand BRENTFORD, ENGLAND, UNITED KINGDOM, May 28, 2026 /EINPresswire.com/ -- The global …
- ETMarkets PMS Talk | A 'private equity approach' to public markets has driven our investing success for 15 years: Sameer Shah May 28, 2026 6:05 am The Economic Times In an era where passive investing, benchmark tracking and broad diversification dominate investor conversations, Sameer Shah believes long-term wealth creation still comes from identifying transformative business trends early and backing them with …
- Tata-backed MedTherapy claims CAR-T breakthrough with one-day production May 27, 2026 11:15 pm ETManufacturing.in CAR T-cell therapy is a personalised immunotherapy, used in advanced malignancies, that genetically reprograms a patient's own white blood cells (T cells) to destroy cancer cells. Mumbai: Tata Sons-backed biotech startup MedTherapy has claimed a major …
- Hack first, hire later: GCCs turn to hackathons to scout new talent May 27, 2026 8:38 pm ETGCC.in For GCCs seeking to move beyond their traditional reputation as offshore execution centres, hackathons are now offering a pathway to cultivate experimentation while solving business-critical challenges.When more than 3,000 developers gathered in Bengaluru …
- China’s State Support and Pricing Practices in the Biotechnology Sector May 27, 2026 6:27 pm The Foundation for Defense of Democracies (FDD) Introduction Commission Secretary Barton and distinguished members of the Commission, on behalf of the Foundation for Defense of Democracies, thank you for the opportunity to testify before you today. This hearing is timely. China’s biotechnology sector …
- 99 New Pharmaceutical Biotechnology and Healthcare Projects Drive Major Facility Investments in April 2026 May 27, 2026 12:59 pm Santa Maria Times - California JACKSONVILLE, Fla., May 27, 2026 (SEND2PRESS NEWSWIRE) — Industrial manufacturing activity remained strong in April 2026, led by sustained investment from the pharmaceutical, medical device, biotechnology, and healthcare sectors. Industrial SalesLeads …
- Newel Health and Gerresheimer launch strategic collaboration May 27, 2026 11:00 am Northampton Chronicle & Echo The collaboration will support pharmaceutical companies in the era of integrated digital therapies. Newel Health, a company that designs, develops, and operates digital medical devices (SaMD) for life sciences partners, and Gerresheimer, an innovative …
- The top 5 highest paid pharma CEOs in 2025 May 27, 2026 6:30 am BioSpace The top five highest paid CEOs in pharma totaled $157.8 million in 2025, a 24% increase from the year before. Eli Lilly’s high-flying chief executive David Ricks led the pack yet again. Ricks’ compensation package was valued at $36.7 million—a 26% increase …